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Abstract
Background: Cell-derived microvesicles (MVs) have been described as a new mechanism of cell-to-cell communication. MVs
after internalization within target cells may deliver genetic information. Human bone marrow derived mesenchymal stem
cells (MSCs) and liver resident stem cells (HLSCs) were shown to release MVs shuttling functional mRNAs. The aim of the
present study was to evaluate whether MVs derived from MSCs and HLSCs contained selected micro-RNAs (miRNAs).
Methodology/Principal Findings: MVs were isolated from MSCs and HLSCs. The presence in MVs of selected
ribonucleoproteins involved in the traffic and stabilization of RNA was evaluated. We observed that MVs contained TIA,
TIAR and HuR multifunctional proteins expressed in nuclei and stress granules, Stau1 and 2 implicated in the transport and
stability of mRNA and Ago2 involved in miRNA transport and processing. RNA extracted from MVs and cells of origin was
profiled for 365 known human mature miRNAs by real time PCR. Hierarchical clustering and similarity analysis of miRNAs
showed 41 co-expressed miRNAs in MVs and cells. Some miRNAs were accumulated within MVs and absent in the cells after
MV release; others were retained within the cells and not secreted in MVs. Gene ontology analysis of predicted and
validated targets showed that the high expressed miRNAs in cells and MVs could be involved in multi-organ development,
cell survival and differentiation. Few selected miRNAs shuttled by MVs were also associated with the immune system
regulation. The highly expressed miRNAs in MVs were transferred to target cells after MV incorporation.
Conclusions: This study demonstrated that MVs contained ribonucleoproteins involved in the intracellular traffic of RNA and
selected pattern of miRNAs, suggesting a dynamic regulation of RNA compartmentalization in MVs. The observation that
MV-highly expressed miRNAs were transferred to target cells, rises the possibility that the biological effect of stem cells may,
at least in part, depend on MV-shuttled miRNAs. Data generated from this study, stimulate further functional investigations
on the predicted target genes and pathways involved in the biological effect of human adult stem cells.
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Introduction
Cell-to-cell communication is a refined system to ensure proper
coordination among different cell types in tissues. Besides soluble
factors, cell-derived microvesicles (MVs) have been described as a
new mechanism of communication. MVs are plasma membrane-
derived vesicles/exosomes released in the micro-environment by
various cell types [1,2] including stem cells and progenitors [3,4].
Ratajczak et al [3] first described that MVs derived from
embryonic stem cells (ESC) may reprogram hematopoietic
progenitors by a mRNA-dependent mechanism. Quesenberry
and Aliotta have recently suggested [5] that a continuous genetic
modulation of cells through transfer of MVs may be involved in
the continuum change in bone marrow stem cell phenotype. MV-
mediated transfer of genetic information from injured cells to bone
marrow-derived stem cells may reprogram their phenotype to
acquire features of the injured tissue [6]. Conversely, MVs derived
from stem cells may induce de-differentiation of cells survived to
injury with a cell cycle re-entry that may allow tissue regeneration
[7]. We, recently, demonstrated that MVs derived from bone
marrow mesenchymal stem cells (MSCs) contribute to the repair of
acute kidney injury by mRNA transfer [8]. Moreover, MVs
derived from human liver stem cells (HLSCs), a population of
mesenchymal stem cells showing a partial hepatic commitment
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[9], accelerated the morphological and functional recovery of liver
in a model of 70% hepatectomy in rats [10]. It has been suggested
that MVs, after internalization within target cells through surface-
expressed ligands, may transfer not only proteins, bioactive lipids
and mRNAs but also microRNAs (miRNAs) [2,11].
miRNAs are a group of small (21–24nt) noncoding RNAs that
function as post-transcriptional regulators of gene expression by
either triggering mRNA cleavage or repressing translation
[12,13,14]. Valadi described that exosomes derived from mast cells
may shuttle specific subsets of miRNAs [15]. miRNAs have been also
found in peripheral blood MVs of healthy individuals [16] and of
patients with ovarian tumors [17]. Moreover, Yuan et al. showed that
MVs derived from ESC contained abundant miRNAs that can be
transferred to mouse embryonic fibroblasts in vitro [11]. In addition,
the conditioned medium of human ESC-derived MSCs contained
microparticles enriched in pre-miRNAs [18]. The mechanism of
mRNA and miRNA compartmentalization withinMVs has not been
clarified. However it is possible that ribonucleoproteins, that mediate
the fate of RNAs within the cells, could be involved.
The aim of the present study was to investigate whether
ribonucleoproteins which are known to be responsible for the
intracellular traffic and compartmentalization of RNAs, are
present in MVs released from human MSCs and HLSCs.
Moreover, we comparatively investigated the miRNA content of
MVs derived from MSCs and HLSCs and the ability of MVs to
transfer miRNAs in target cells.
Our study demonstrates the presence within MVs released from
MSCs and HLSCs of selected ribonucleoproteins that may
account for mRNA and miRNA storage. In addition, we found
that MVs derived from these cells contained miRNAs specific of
the cell of origin and may serve as a signature for adult stem cells/
MVs. Some miRNAs were found to be selectively accumulated
inside the released MVs suggesting an organized package of
miRNAs. Moreover, miRNAs from MVs were transferred and
accumulated into recipient cells, where they may downregulate
specific targets.
Results
MVs shuttle ribonucleoproteins involved in RNA traffic
We previously demonstrated that MVs derived from MSCs and
HLSCs contained selective patterns of mRNA (microarray data
were deposited on GEO database as geo accession GSE 12243
and GSE15569 respectively). To investigate the mechanism of
RNA transport by MVs, we evaluated the presence in MVs of
selected ribonucleoproteins involved in the traffic of RNAs from
nucleus to cytoplasm and in the RNA stabilization. As shown in
figure 1, MVs derived from MSCs contained ribonucleoproteins as
seen by Western blot, immunofluorescence and immunogold
electron-microscopy. MVs contained T cell internal antigen-1
(TIA), TIA-1-related (TIAR) and AU-rich element binding protein
(HuR), multifunctional proteins expressed in nuclei and stress
granules [19], and proteins involved in the transport and stability
of mRNA such as staufen1 (Stau1) and 2 (Stau2) [20]. Similar
results were obtained with MVs derived from HLSCs (not shown).
In addition, MVs derived from MSCs contained argonaute2
(Ago2), a protein of the argonaute family which is involved in
miRNA transport and processing [21]. At variance with stress
granules, MVs did not contain the human ribosomal protein S29
(RPS29) (Figure 1C). These results suggest that the RNA content
of MVs released from MSCs and HLSCs was modulated by the
same ribonucleoproteins involved in the intracellular trafficking of
RNA among nucleus, polyribosomes, stress granules, P bodies and
MVs/exosomes (Figure 1F).
Cytoskeleton is involved in the release of MVs
To analyze the involvement of actin polymerization and
cytoskeleton activation in MV release, we evaluated the number
of MVs secreted by MSCs and HLSCs after cell pre-treatment
with an inhibitor of actin polymerization, cytochalasin B [22]. Pre-
treatment with 10 mg/ml of cytochalasin B, significantly reduced
the MV release from MSCs and HLSCs (Figure 2A-C). Moreover,
the inhibition of MV release by cytochalasin B was associated with
an enhanced expression of stress granules within the cells, detected
by the accumulation of TIA and Stau2 granules (Figure 2D).
Profiling of miRNAs in MSCs and HLSCs
We performed comparative miRNA expression profiling
analyses of 365 human mature miRNAs in two different lines
of MSCs and HLSCs. We analyzed only the miRNAs similarly
modulated in the two preparations of MSCs and HLSCs,
respectively to focus on maintained miRNA patterns. Despite
a qualitative difference, the number of miRNAs expressed by
MSCs and HLSCs was similar, i.e. 145 and 139 mature
miRNAs. The expression of the small nuclear RNAs (snoRNAs)
used as internal controls was similar in MSCs (RNU6b: 32.561,
RNU48: 23.960.2 and RNU44: 22.960.5, raw cycle threshold
values, Ct) and HLSCs (RNU6b: 32.861.4, RNU48: 24.360.2
and RNU44: 22.660.2, raw Ct values), confirming the correct
setting of the experiments. To reduce sample variations among
different arrays, miRNAs were compared between MSC and
HLSC samples, based on their cycle threshold (Ct) values
normalized to the mean expression value, calculated on the
overall miRNA expression in each array according to Mestdagh
[23]. Normalized MSC and HLSC data were then subjected to
hierarchical clustering analysis to compare their miRNA
expression. In Table 1, miRNA expression was analyzed
separately in MSCs and HLSCs to determine the most expressed
miRNAs by both cell types. MSCs and HLSCs shared a
common pattern of 9 miRNAs which were highly expressed in
both cell types (Table 1). Moreover, MSCs expressed higher level
of miR-21 than HLSCs whereas HLSCs expressed higher level
of miR-19b than MSCs.
To compare miRNA profile of MSCs and HLSCs, we
performed clustering similarities between these two cell types, to
detected groups of conservative or differentially modulated
miRNAs. Normalized expression data were reanalyzed generating
3 different groups of miRNA expression for MSCs and HLSCs
(see Methods). MSCs and HLSCs shared 128 miRNAs (Figure 3A),
98 of which clustered in the same expression group, suggesting a
common origin of the two populations. Moreover, they showed 4
miRNAs selectively expressed by HLSCs (miR-7, -95, -204 and -
650) and 8 by MSCs (miR-196b, -196a, -615, -501, -449, -17-3p, -
497 and-486) (Table 2). Among miRNAs expressed by both cell
types that clustered in same expression groups, we found that 32
miRNAs were more than 2-fold increased in MSCs compared to
HLSCs and 3 miRNAs in HLSCs in respect to MSCs (Table S1),
possibly reflecting the influence of the local niche in establishing
specific miRNA patterns.
MVs from MSCs and HLSCs are enriched of mature
miRNAs
We performed the same miRNA profiling of MVs purified from
MSCs and HLSCs to test the hypothesis that MVs are enriched of
mature miRNAs. A bioanalyzer profile on total RNA from MVs
and their cells of origin revealed that MVs contained a broad
range of RNA sizes, with a relevant peak characteristic of small
RNA classes (Figure 4A and B). The enrichment in miRNAs was
Stem Cell MVs and miRNAs
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confirmed by the high percentage of the small RNAs detected in
MVs that fell within the miRNA range of 10–40 nucleotides (48%
in HLSC MVs and 32% in MSC MVs) (Figure 4C).
miRNA profile was conducted on these samples after Ct raw
data normalization [23]. The content of control snoRNAs,
RNU48 and RNU44, in MVs was significantly lower than that
present within the cells of origin as previously shown for different
mRNAs [8,11]. For this reason, RNU48 and RNU44 were not
used to normalize miRNA expression in MVs, instead a
normalization analysis was performed using mean expression
values derived from the overall miRNA expressed in each array
[23]. Normalized MV and cell filtered data were then subjected to
hierarchical clustering analysis to compare their miRNA expres-
sion generating clusters for each sample that were compared
between all the cells and MVs or between cells and the
corresponding MVs. We detected the presence of 113 mature
miRNAs expressed by MSC MVs and 133 by HLSC MVs.
Figure 3 underlines the similarities observed among MSCs,
HLSCs and their MVs based on the relative miRNA expression.
In particular, we found 91 miRNAs detected in both MVs and
cells, showing the same pattern between MVs and their cell of
origin but different level of miRNA expression. Among miRNAs
expressed by both cells and MVs only 41 clustered in same
expression groups (see Methods). Table 3 shows the miRNAs
shared by MVs and their cells of origin that represented the most
abundant miRNAs conserved in the cells and transported in MVs.
The presence of miR-24 highly expressed by both cell types and
MVs was confirmed by in situ hybridization that showed the
accumulation of miR-24 inside MSCs as a punctuate pattern and
in MSC MVs (Figure 4 D and E). Same results were obtained with
HLSCs and HLSC MVs (not shown). Moreover, miR-24
accumulation on MVs was also detected by immunogold
electron-microscopy as shown in figure 4F. We observed also that
MVs expressed a group of miRNAs described as ‘‘selectively’’
expressed by MSCs [24], such as miR-103-1, -140, -143-5p and -
340 (not shown).
Figure 1. Expression of ribonucleoproteins within MVs. Panel A. Representative micrographs showing the presence of stress granule
expressing Stau2 and TIA ribonucleoproteins as detected by confocal microscopy in MSCs cultured overnight in the absence of serum. Panel B:
representative confocal micrographs showing the expression of Stau2 and Ago2 by MVs released from MSCs cultured overnight in the absence of
serum. MVs were labeled with the red PKH26 dye. Merge shows the co-localization of Ago2 and Stau2 within MVs. MVs from MSCs expressed also
Stau1, TIA, TIAR and HuR (not shown). (Panel A; original magnification X400. Panel B; original magnification X600). Panel C: representative western
blot analysis showing the expression of Stau1, Stau2, TIA, TIAR, HuR, Ago2 and RPS29 by MVs derived from MSCs. Head arrows indicate the expected
molecular weight. Panel D: Representative micrographs of transmission electron microscopy obtained on purified MVs. Ultrathin sections, stained
with lead citrate. Panel E: Immunogold electron microscopy showing staining for Stau2 and Ago2 (see Methods). MVs were viewed by JEOL Jem 1010
electron microscope (black line = 100 nm). All experiments were performed three times with similar results. Panel F: schematic representation of
ribonucleoprotein mediated RNA intracellular traffic, suggesting that MVs/exosomes may represent a site of RNA compartmentalization allowing the
transfer of genetic material to target cells.
doi:10.1371/journal.pone.0011803.g001
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In addition, we were able to detect a group of miRNAs that
resulted unique for MVs compared to the cells of origin whereas
some miRNAs expressed by cells were absent in the correspond-
ing MVs (Figure 3 B and C). In particular, 10 miRNAs were
detected only in HLSC-derived MVs whereas 8 miRNAs were
present in HLSCs and not in their MVs (Table 4). MSC-derived
MVs expressed selectively only 3 miRNAs in respect to their cells
of origin, instead 7 miRNAs were only detected in MSCs
(Table 5).
As shown in figure 5, the relative abundance of several miRNAs
in MVs derived from MSCs and HLSCs in respect to their cells of
origin, was confirmed by quantitative real time-PCR (qRT-PCR)
using the Syber green technique, supporting the data obtained by
the MicroRNA Assay Panel. In particular, we observed that 9
miRNAs were co-expressed and 3 enriched in MVs from both
MSCs and HLSCs (Figure 5). The finding that miRNAs at
variance with mRNAs exhibited the same level or were even
enriched within MVs suggests the compartmentalization of
selected miRNAs in MVs before their release.
Cell processes over-represented by target genes
associated with the MV-miRNAs
To characterize the cell processes modulated by highly expressed
miRNAs, we analyzed the potential targets associated with the most
abundant miRNAs conserved in the cells and transported by MVs
(Table 3). Using the miRWalk database (see Methods), we detected
966 validated and 1,075 predicted genes associated with the highly
co-expressed miRNAs in both cells and MVs. To characterize the
biological processes overrepresented by these targets, we generated a
network derived from the union of validated and predicted genes and
we performed a gene ontology (GO) enrichment analysis using
BiNGO 2.3 [25], a Cytoscape [26] plugin. Among the validated and
predicted targets, 766 and 810 genes respectively, showed a GO
annotation. In figure 6, it is shown a GO tree representing a
hierarchical structure of the GO biological processes, in which the
colored nodes indicate significantly overrepresented GO biological
functions (p,0.01). We were able to identify in the overrepresented
processes, four different groups: metabolic processes, developmental
processes, catalytic activity and cell fate and differentiation. Among
Figure 2. Effect of cytochalasin B on MV release and stress granule accumulation. Panel A and B: The release of MVs by MSCs (A) and
HLSCs (B) was evaluated using the gating strategy described by Wysoczynsk [19]. Size beads were used to define the proper gate of MVs, as events
under 1 mm. The stopping gate was set up on 1,000 events collected from the cells region (R1). Panel C: The number of MVs was evaluated by flow
cytometry at 6 h for MSCs and 24 hours for HLSCs after 1 hour treatment with cytochalasin B (white bar, cyt B) or with vehicle alone (black bar, CTR).
Data are expressed as mean 6 1SD of 5 experiments. Nonparametric Mann-Whitney t test = * p,0.05. Panel D: representative confocal micrographs
of TIA and Stau2 expression by stress granules in MSCs pre-treated with cytochalasin B (cyt B) or vehicle (CTR) as described in Methods. Five
experiments were performed with similar results.
doi:10.1371/journal.pone.0011803.g002
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these groups, stem cell-related functions were detected, in particular
development and differentiation-related functions, cell cycle-,
proliferation- and cell death program-related processes were present
(Table S2). Interestingly, these observations suggest that MV- and
cell-enriched miRNAs can contribute to promoting cell prolifera-
tion/differentiation in target cells. Despite the similarities at the
global level between the MV- and cell-derived miRNAs, we
identified a group of miRNAs selectively expressed by MVs. The
same GO analysis was conducted on MV-enriched miRNAs, to
analyze the potential targets selectively regulated by the most
abundant miRNAs transported in MVs but absent in cells after MV
release. HLSC MV-enriched miRNAs (Table 4) resulted associated
with 75 GO annotated genes (validated). Instead, MSC MV-
enriched miRNAs (Table 5) were related to 42 validated target genes
with a GO annotation. Interestingly, for both types of MV-enriched
miRNAs, the GO biological processes that resulted highly
represented were associated to metabolism, such as macromolecule
metabolic processes and positive regulator of metabolic processes of
RNA and DNA (p value:MSCMVs, 5.73E-12 and 4.61E-11; HLSC
MVs, 5.89E-17 and 1.86E-16 respectively) (Table S3 and S4).
Moreover, development related GO functions, including multicel-
lular organism development, system and organ development and cell
differentiation, assumed a relevant role in MV-enriched miRNAs
GO classification in both MV types. Gene expression related
processes such as transcription regulation and biosynthetic functions
such as macromolecule biosynthesis (Table S3) were overrepresented
in HLSC-derived MVs (19 and 20 out of 75 genes; p value: 9.06E-16
and 6.50 E-16 respectively). Surprisingly, MSC-derivedMV selected
miRNAs were associated to targets involved in the immune system
processes, including leukocyte activation and differentiation and
hemopoiesis regulation (Table S4).
MSC-derived MVs are incorporated by murine tubular
epithelial cells and transfer miRNAs
The presence of enriched miRNAs in adult stem cell MVs
prompted us to investigate whether MVs may transfer miRNAs to
target cells. To test this hypothesis murine tubular epithelial cells
(mTEC) were incubated with MVs derived from MSCs in the
presence of a-amanitin to inhibit transcriptional activation [27]
and the transfer of selected miRNAs was evaluated by qRT-PCR.
The variation in Ct values in mTEC stimulated with MVs was
evaluated in respect to mTEC treated with a-amanitin in the
absence of MVs. The abundance of some miRNAs (miR-21, miR-
100, miR-99a and miR-223) increased progressively in mTEC
concomitantly with the internalization of PKH26- labeled MVs
(Figure 7A and B). MV internalization and accumulation of
miRNAs peaked between 12 and 24 hours to decrease at
48 hours. However, this was not observed with all miRNAs
tested. The miRNAs transferred most efficiently were those found
in abundance in MVs. The RNU48, low expressed in MV, was
less accumulated than the most abundant miRNAs. miR-410, not
present in MVs, was not transferred to mTEC (Figure 7A). This
suggested that the increase in specific miRNA content was due to
their transport from MVs to the target cells. Moreover, the transfer
of miRNAs within mTEC was confirmed using two fluorescent
labeled reporter miRNAs carried by MVs derived from MSCs
transfected with Alexa-488 labeled siRNA or with FAM labeled
miRNA Mimics (hsa-miR-21 and hsa-miR-100). As seen by
confocal microscopy, mTEC showed after 3 hour incubation with
MVs a fine granular fluorescent pattern within their cytoplasm
indicating the incorporation of the reporter Alexa-488 siRNA or
FAM hsa-miR-21 (Figure 7C). Similar results were obtained with
FAM hsa-miR-100 (not shown). Moreover, the incubation of
mTEC with MVs derived from MSCs resulted in the reduction of
proteins known to be targeted by some of the enriched miRNAs
found in MVs (Figure 7D). In particular, the following target
proteins were downregulated: PTEN which is known to be
targeted by miR-21 [28,29], cyclin D1 which is known to be
targeted by miR-100, miR-99a and miR-223 [30] and Bcl-2 which
is known to be targeted directly by miR-34, miR-181b and miR-
16 [31,32,33] or indirectly modulated by miR-21 [34]. No
downregulation was observed for AKT and for actin, used as
control.
Discussion
The results of the present study demonstrated that MVs
contained ribonucleoproteins involved in the intracellular traffic
of RNAs suggesting a dynamic regulation of RNA compartmen-
talization in the MVs released from human adult stem cells of
mesenchymal origin. Moreover, MVs derived from MSCs and
HLSCs, contained selective patterns of miRNAs which may be
transferred to target cells.
Cell communication represents a dynamic mechanism regulated
by the release of factors able to influence cell fate, function and
plasticity. Recently, MVs/exosomes have been described as a
potent paracrine mechanism that may re-direct cell fate through
the active transfer of proteins, functional mRNAs and miRNAs
[7,35].
MVs may be released from the endosomal compartment after
fusion with the plasma membrane [36,37] or as shedding vesicles
after budding and detachment of small cytoplasmic protrusions
[38]. MVs present in the circulation, are a heterogeneous
population that differs in size, antigenic composition and in
cellular origin [39]. In physiological conditions, MVs in blood are
derived mainly from platelets [40], and in lesser extent from other
blood cells and endothelial cells [41]. It is now recognized that
MVs from different cells may be internalized in target cells
through specific receptor-ligand interactions [42] and transfer
signals that may functionally affect them. It has been recently
Table 1. Normalized expression analysis of miRNAs in MSCs
and HLSCs.
MSCs HLSCs
miRNAs
Normalized
Expression ±S.D. miRNAs
Normalized
Expression ±S.D.
hsa-miR-125b 157.2644.7 hsa-miR-24 52.5612.8
hsa-miR-222 120.1610.7 hsa-miR-222 48.9618.8
hsa-miR-24 70.9625.4 hsa-miR-99a 43.367.5
hsa-miR-99a 67.965.4 hsa-miR-125b 37.860.2
hsa-miR-100 62.660.0 hsa-miR-100 37.260.3
hsa-miR-594 40.363.2 hsa-miR-31 30.9612.3
hsa-miR-31 33.268.4 hsa-miR-19b 25.364.3
hsa-miR-16 29.463.1 hsa-miR-16 21.463.4
hsa-miR-125a 29.361.4 hsa-miR-594 18.864.2
hsa-miR-21 20.462.7 hsa-miR-125a 16.763.5
Expression of miRNAs in MSCs and HLSCs was analyzed separately (n = 4).
miRNAs were clustered in each sample and compared intra-sample to detected
conservative miRNAs inside the MSCs and HLSCs. Normalized miRNA expression
was generated using the mean expression value normalization then the mean
Ct was converted into expression (22DCt) 6 SD. The top ten highly expressed
miRNAs in MSCs and HLSCs are reported.
doi:10.1371/journal.pone.0011803.t001
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shown that stem/progenitor cells are a potential source of MVs
suggesting that they may play a role in stem cell biology [5]. The
recent finding that MVs may carry selected patterns of mRNAs
and miRNAs suggests that MVs may represent a new mechanism
of genetic exchange between cells [3,4,11,43]. Ratajczak et al. [3]
demonstrated that MVs released from ESC may reprogram
hematopoietic progenitors by delivering mRNAs and proteins. We
demonstrated that MVs from endothelial progenitor cells may
activate in normal endothelial cells an angiogenic program by
transfer of functional mRNAs [4]. Recently, it has been shown
that MVs derived from ESC may transfer in target cells not only
mRNAs but also mature miRNAs [11]. The mechanism of mRNA
and miRNA compartmentalization and in particular whether
RNAs are accumulated into MVs in a random or organized
Figure 3. Venn diagram comparing miRNA expression in HLSCs, MSCs and their MVs and expression profile of common miRNAs.
Panel A–C: the number of shared and specific miRNAs for MSCs and HLSCs (A), for MSCs and MSC MVs (B) and for HLSCs and HLSC MVs (C) are shown.
Panel D: Heat map demonstrating the expression profile for MSCs, HLSCs and the corresponding MVs is generated for commonly expressed miRNAs.
doi:10.1371/journal.pone.0011803.g003
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manner remain to be defined. However, recent studies [18,44] as
well as the present results suggest a selective mechanism of RNA
packaging into MVs. Monitoring the ribonucleoproteins involved
in the intracellular traffic of RNAs and comparing the species of
miRNAs contained in MVs and cells of origin may provide
information on the mechanism of RNA accumulation within MVs.
We found that MVs released from MSCs and HLSCs contained
stress granule specific proteins. In particular, MVs contained
ribonucleoproteins involved in the RNA storage. TIA, TIAR and
HuR have been detected inside MVs from both MSCs and
HLSCs, together with Stau 1 and 2, proteins expressed in nuclei
and stress granules but not in P-bodies [45]. The absence of P-
body specific proteins was also observed in exosomes released from
cultured monocytes which however contained proteins involved in
miRNA organization such as Ago2 and GW182 [44]. We also
observed the presence of Ago2 in MVs derived from MSCs. These
data suggest a role for ribonucleoproteins in the RNA transport,
storage and stability within MVs. At variance of stress granules
[45], MVs did not contain the ribosomal protein, RPS29. The
secretion of MVs was shown to be dependent on cytoskeleton
activation as cytochalasin B inhibited their release and favored the
accumulation of stress granules within the cells as detected by the
increase of stress granule specific proteins, TIA and Stau2, inside
MSCs treated with cytochalasin B. This observation is consistent
with the previously reported enhancement of stress granules in
cells treated with cytochalasin B [46]. Taken together these results
suggest that ribonucleoproteins may shuttle RNAs from different
cytoplasmic compartments including MVs/exosomes [47] possibly
accounting for the specific accumulation of mRNAs and miRNAs
in these structures.
miRNAs have been described as potential regulators of self
renewal [48], plasticity [49] and differentiation potential of many
stem cell types including MSCs [50,51,52]. This supports the
theory that miRNA patterns may be used as signatures to define
and track different cell populations [53,54]. In the present study
we adopted a two-phases approach consisting in a hierarchical
clustering followed by a similarity analysis measuring the equalities
or differences between miRNAs from MSCs, HLSCs and their
MVs. With this approach, we defined a pattern of relevant
miRNAs showing the same behavior among cells and MVs. The
examination of predictive targets modulated by the most highly
expressed miRNAs in MSCs and HLSCs and their MVs
demonstrated that many of these miRNAs could be involved in
multi-organ development, cell survival and differentiation. In fact,
as reported herein, miRNA patterns may be used as signatures to
define the cellular origin of MVs. Interestingly, 5 miRNAs
selectively present in MSCs (see Table 2) were known to be
expressed by bone marrow (mirWalk database), indicating a tissue
specificity. Moreover, we confirmed that MVs derived from MSCs
expressed a group of miRNAs specific for MSCs [24]. MSCs and
their MVs co-expressed also miR-335, poorly detected in HLSCs
and HLSC MVs, described as a specific bone marrow-derived
MSC miRNA [24].
The comparative screening of miRNA content of MVs and
adult stem cells may provide information on the mechanism of
RNA accumulation within MVs. In particular, miRNA profile on
MVs from MSCs and HLSCs showed that MVs contained a
pattern of miRNAs shared with their cells of origin. However,
selected miRNAs were detectable only in the released MVs but
absent in the MSCs and HLSCs from which they derived
supporting the theory of a specific and organized package of
miRNAs in MVs before their secretion. When the miRNA content
of HLSC MVs was compared with that of the cells of origin, miR-
223, miR-142-3p and miR-451 represented the most highly
differentially expressed miRNAs. When the miRNA content of
MSC-derived MVs was compared with that of the cells of origin,
miR-223, miR-564 and miR-451 represented the three selectively
expressed miRNAs in MVs. Instead, miR-378, miR-10b and miR-
95 were expressed mainly in HLSCs and miR-369-5p, miR-594
and miR-654, were expressed mainly in MSCs rather than in their
MVs, suggesting that these miRNAs were not compartmentalized
within MVs and therefore not secreted. Interestingly, both MVs
from MSCs and HLSCs showed the selective expression of miR-
451 and miR-223, not detected in their cells of origin after the MV
release. Previous research indicated that miR-451 is involved in
the specific differentiation of erythrocytes [55,56]. However, high
expression of miR-451 has been detected in other tissues,
suggesting that numerous cell types may require miR-451 for
their maintenance and/or differentiation [57]. Moreover, miR-
451 deficiency has been associated to a poor prognosis in gastric
cancers [58]. Interestingly, also miR-223 was predicted to
influence cell differentiation and development [59], in particular
miR-223 appears to have a role in hematopoietic stem cell
proliferation [60]. A recent report showed that miR-223 was the
most highly expressed miRNA in peripheral blood mononuclear
cells, platelets and their plasma microvesicles [16]. Moreover,
miR-223 has been also involved as regulator of cell cycle in cancer
with an inverse correlation with cancer progression [61].
The presence of enriched miRNAs in adult stem cell MVs
allowed us to demonstrate that MVs may transfer miRNAs to
target cells. Indeed, we found that miRNAs highly expressed
within MVs were transferred in mTEC after internalization of
MVs. This observation is consistent with that of Yuan et al. [11]
who demonstrated that miRNAs derived from ESC may be
transferred to fibroblasts. Moreover, it has been described that
specific miRNAs carried by apoptotic bodies are delivered to
target cells and directly or indirectly regulate specific genes
[62,63]. Interestingly, we found that MVs may deliver to target
cells not only endogenous miRNAs but also traceable synthetic
miRNAs. Moreover, we found that miRNAs shuttled by MVs are
functional because able to downregulate proteins such as Bcl-2,
cyclin D1 and PTEN, known to be targeted by selected miRNAs.
These data suggest that MVs may act as mediators of cell to cell
communication also through miRNA delivery.
Table 2. miRNAs selectively expressed by MSCs and HLSCs.
miRNAs
Expression
in HLSCs Fold change
Expression
in MSCs Fold change
hsa-miR-650 30.864.8 hsa-miR-196b 1324.66416.2
hsa-miR-95 30.3611.7 hsa-miR-196a 731.760.95
hsa-miR-7 1167.75 hsa-miR-615 606.26145.6
hsa-miR-204 8.765.5 hsa-miR-501 123.5689.2
hsa-miR-449 24.6614.3
hsa-miR-17-3p 18.1612.1
hsa-miR-497 8.560.6
hsa-miR-486 6.560.7
Based on the analysis of clustering similarities on all cell samples, miRNAs
present only in one of the two cell types, were defined as selectively expressed
by MSCs or HLSCs. Based on this model miRNAs were classified to determine
the different pattern of miRNAs detected in both cell types. Fold change was
measured based on the normalized miRNA mean differences (22DCt) 6 SD,
between cell samples.
doi:10.1371/journal.pone.0011803.t002
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Figure 4. Bioanalyzer profile of RNA extracted fromMSCs, HLSCs and the corresponding MVs andmiRNA expression seen by in situ
hybridization in cells and MVs. Panel A and B: Representative bioanalyzer profile of the RNAs contained in MSCs, HLSCs and MVs showing that,
whereas the ribosomal subunit 28 and 18S were detectable in cells, they were absent or barely detectable in the corresponding MVs. MVs exhibited a
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In conclusion, the results of the present study suggest the
presence of a regulated mechanism of miRNA accumulation
within MVs and their transfer to neighbor cells. The prediction of
defined functions of miRNAs shuttled by MVs derived from adult
stem cells suggests that they may be important factors in autocrine
and paracrine regulation of development, differentiation and cell
survival.
Methods
Isolation and Characterization of Human MSCs and
HLSCs
Approval of the study was obtained from the Molecular
Biotechnology Center (University of Torino) Institutional Review
Board. MSCs were obtained from Lonza (Basel, Switzerland),
cultured and characterized as previously described by Bruno [8].
HLSCs were isolated from human cryopreserved normal adult
hepatocytes (Lonza). HLSC isolation, culture and characterization
were performed as previously described [9]. MSCs and HLSCs
were used within the sixth passage of culture. At each passage, cells
were counted and analyzed by cytofluorimetric analysis and
immunofluorescence to confirm their phenotype. Cells were
characterized by FACS analysis for the expression of mesenchymal
stem cell markers, and in the case of HLSCs also for the expression
of tissue specific markers, as previously described [9]. Both cells
were able to undergo osteogenic, adipogenic and chondrogenic
differentiation when cultured in the appropriate differentiative
media [8,9]. HLSCs were also able to differentiate in mature
hepatocytes [9].
Isolation of MVs
MVs were obtained from supernatants of MSCs and of HLSCs
as previously described [8,10]. Briefly, MSCs were cultured in
RPMI deprived of fetal calf serum (FCS) and supplemented with
0.5% of bovine serum albumin (BSA) (Sigma-Aldrich, St. Louis,
MO). HLSCs were cultured overnight in a-MEM deprived of
FCS. The viability of both cell types at the time of MV collection
was .99% as detected by trypan blue exclusion. After
centrifugation at 2,000 g for 20 minutes to remove debris, cell-
free supernatants were ultracentrifuged at 100,000 g (Beckman
Coulter Optima L-90K) for 1 hour at 4uC, washed in serum-free
medium 199 containing Hepes 25 mM (Sigma) and submitted to a
second ultracentrifugation in the same conditions [9]. The protein
content of MV preparations was quantified by Bradford method
(Bio-Rad, Hercules, CA, USA). In selected experiments, MVs
were labeled with the red fluorescence aliphatic chromophore
intercalating into lipid bilayers, PKH26 dye (Sigma). After
labeling, MVs were washed and ultracentrifuged at 100,000 g
for 1 h at 4uC. Endotoxin contamination of MVs was excluded by
Limulus test (Charles River Laboratories, Inc., Wilmington, MA,
USA) according to the manufacturer’s instruction, and MVs were
stored at –80uC. The analyses on MV suspension after staining
with propidium iodide did not show the presence of apoptotic
bodies.
Cytofluorimetric quantification of MVs released from
MSCs and HLSCs
MSCs and HLSCs were seeded in a 12-well tissue culture plate
and cultured in their complete media until 80% of confluence.
relevant peak of small RNAs at variance with the cells. Panel C: Representative bioanalyzer profile of small RNAs performed on MVs derived from MSCs
and HLSCs (MSC MVs and HLSC MVs) showing an enrichment of small RNAs (range: 30–50%) of the size of miRNAs in respect to the cells of origin
(range: 4–8%; not shown). Three different samples tested in triplicate were analyzed for each type of cells and MVs with similar results. Panel D–F:
Representative micrographs of in situ hybridization on MSCs (D) and MSC-derived MVs (E and F) using a probe for miR-24 or a scramble-miR probe
(miR-Scr) as control. Confocal microscopy original magnification X400 (D) and X600 (E). In panel E, MVs were labeled with a red dye PKH26. Panel F:
The in situ hybridization was revealed by immunogold transmission electron microscopy as described in Methods (original magnification X50,000).
Three different experiments were performed with similar results.
doi:10.1371/journal.pone.0011803.g004
Table 3. Expression analysis of miRNAs co-expressed by MVs
and cells.
Normalized Expression ±S.D.
miRNAs MSCs MSC MVs HLSCs HLSC MVs
hsa-miR-125b 296.2682.55 66.1657.6 51.360.25 20.463.15
hsa-miR-222 222.25619.7 39.1620.2 68.7625.5 43.264.2
hsa-miR-24 135646.85 40.75629.6 72.3617.4 54.4618.5
hsa-miR-99a 125.769.9 23.7614.1 59.1610.2 15.061.8
hsa-miR-100 115.560.1 27.8619 50.560.4 20.966.3
hsa-miR-31 62.2615.5 14.669.4 43.55616.7 30.55617.6
hsa-miR-16 54.465.7 21.6611.8 29.1564.6 22.45617.4
hsa-miR-125a 54.262.6 8.665.5 22.964.8 9.760.85
hsa-miR-21 43.7615.6 31.9635.7 22.264.7 12.563.8
hsa-miR-221 33.369.5 10.365.8 13.561.1 8.963.5
hsa-miR-19b 25.060.8 9.464.7 34.565.9 27.2615.7
Expression of miRNAs in MSCs, HLSCs and their corresponding MVs was
analyzed separately (n = 8), miRNAs were clustered based on their normalized
mean expression value and compared inter-sample to detected conservative
miRNAs inside the adult stem cells and their MVs. miRNAs classified in the first
expression group are shown and expressed as (22DCt) 6 SD.
doi:10.1371/journal.pone.0011803.t003
Table 4. Selectively expressed miRNAs from HLSC MVs and
their cells of origin.
miRNAs
Expression
in HLSCs Fold change
Expression
in HLSC MVs Fold change
hsa-miR-10b 186.356175.55 hsa-miR-223 1003.86715.35
hsa-miR-378 96.1676.8 hsa-miR-142-3p 437.1643.95
hsa-miR-95 87.3633.7 hsa-miR-451 403.76164.8
hsa-miR-432 62.7612.6 hsa-miR-501 324.46179.2
hsa-miR-642 35.8627.7 hsa-miR-486 61.768.4
hsa-miR-143 27.363.6 hsa-miR-627 59.6642.9
hsa-miR-199b 10.165.4 hsa-miR-142-5p 59.168.4
hsa-miR-502 8.661.1 hsa-miR-383 16.0568.4
hsa-miR-601 7.262
hsa-miR-17-3p 5.960.3
Expression of miRNAs in HLSCs and their corresponding MVs was analyzed
separately (n = 4). Clustering similarities of MVs derived from HLSCs and their
cells of origin detected miRNAs present only in HLSCs or their MVs. Data are
expressed as fold change measured based on the normalized miRNA mean
differences (22DCt) 6 SD, between HLSCs and their corresponding MVs.
doi:10.1371/journal.pone.0011803.t004
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Cells were then incubated for 1 hour with vehicle (complete
medium) or with 10 mg/ml of cytochalasin B (Sigma). After
washing, culture media were replaced with serum-free media
(0.5% of BSA) to induce MV release. Subsequently, 6 and
24 hours later, the number of secreted MVs in respect to the
number of cells, was evaluated using flow cytometry by gating
events smaller than 1 mm. Size beads (1–4–10 mm, Molecular
Probes, Invitrogen, Carlsbad, CA) were used to establish the
proper gate for events smaller than 1 mm, which include MVs.
The stopping gate was set up on 1,000 events collected from the
cell region [64]. Cell viability at the time of MV collection was
.99% as detected by trypan blue exclusion.
RNA extraction
Total RNA was isolated from different MV and cell
preparations using the mirVana RNA isolation kit (Ambion)
according to the manufacturer’s protocol. RNA was then
quantified spectrophotometrically (Nanodrop ND-1000, Wilming-
ton DE) and the RNA quality was assessed by capillary
electrophoresis on an Agilent 2100 Bioanalyzer (Agilent Technol-
ogies, Inc, Santa Clara, CA) where the presence of small RNAs
was verified in both MV and cell samples. For RNA isolated from
MSCs and HLSCs, only a RNA integrity number (RIN) $9 was
used. Since the intact 18S and 28S rRNAs were scarcely
detectable in the MVs, the RIN was not a constraint for these
samples.
miRNA profiling by quantitative real-time PCR
miRNA expression levels were analyzed using the Applied
Biosystems TaqManH MicroRNA Assay Human Panel Early
Access kit (Applied Biosystems, Foster City, CA) to profile 365
mature miRNAs by qRT-PCR. The kit used gene-specific stem-
loop reverse transcription primers and TaqMan probes to detect
mature miRNA transcripts in a 2-step real-time reverse-transcrip-
tion PCR assay. Briefly, single stranded cDNA was generated from
total RNA sample (80 ng) by reverse transcription using a mixture
of looped primers (Multiplex RT kit, Applied Biosystems)
following manufacturer’s protocol. The RT reactions were then
diluted and mixed with a Taqman universal master Mix (Applied)
in a ratio 1:1, loaded in the TaqMan micro-fluid card and qRT-
PCR experiments were performed. All reactions were performed
using an Applied Biosystems 7900HT real-time PCR instrument
equipped with a 384 well reaction plate. Raw Ct values were
calculated using the SDS software version 2.3. using automatic
baseline and threshold.
Another approach of qRT-PCR was used to confirm some
miRNAs screened by microarray analysis. Briefly, 200 ng of input
RNA from all samples was reverse transcribed with the miScript
Reverse Transcription Kit and the cDNA was then used to detect
and quantify miRNAs of interest by qRT-PCR using the miScript
SYBR Green PCR Kit (all from Qiagen, Valencia, CA, USA). All
samples were run in triplicate using 3 ng of cDNA for each
reaction as described by the manufacturer’s protocol (Qiagen).
miRNAs specific primers to hsa-miR-221, -99a, -222, -24, -21,
-100, -214, -31, -410, -16-1, -181b, -223, -122 and -451 were used
in separate reactions. The snoRNAs, RNU48 and RNU44 were
used as positive controls. Negative controls using 10 ml of water in
place of the RNA were performed alongside each reaction. qRT-
PCR was performed using a 48- well StepOneTM Real Time
System (Applied Biosystems). miRNA comparisons between cells
and MVs were performed on the relative expression data
normalized using the geometric mean value of four of the most
stable miRNAs identified in the profiling between cells and MV
(miR-21, -221, -16-1, and 181b for HLSCs and HLSC MVs; miR-
21, -221, -16-1, and 24 for MSCs and MSC MVs). Fold change in
miRNA expression was calculated based on the normalized mean
differences between cells and the corresponding MVs (22DCt).
Detection of RNA-binding proteins in cells and MVs
Indirect immunofluorescence was performed on cells cultured
on chamber slides (Nalgen Nunc International, Rochester, NY) or
PKH26-labeled MVs spotted on glass slides, fixed in 4%
paraformaldheyde in PBS containing 2% sucrose for 15 min and
permeabilized with cold methanol (220uC) as described by
Kedersha and Anderson [65]. After blocking with 1% BSA in
PBS, samples were incubated with the following primary
antibodies (1:100 dilution) mouse anti-human Ago2 (AbCam,
Cambridge Science Park, UK), goat anti-human TIA1, goat anti-
human TIAR, mouse anti-human HuR (Santa Cruz Biotechnol-
ogy, Santa Cruz CA), rabbit anti-human Stau1, mouse anti-
human Stau2 (AbCam) and rabbit anti-human RPS29 (AbCam).
After washings cells were incubated with the appropriate
secondary antibodies at 1:1,000 dilution (goat anti-mouse or
donkey anti-goat labeled with Texas red or Alexa Fluor 488;
Molecular Probe, Invitrogen). Cell nuclei were stained with DAPI
(Sigma). Confocal microscopy analysis was performed using a
Zeiss confocal microscope, model LSM 5 PASCAL (Carl Zeiss
International, Germany).
Electron microscopy of MVs
MVs from MSCs or HLSCs were suspended in PBS and loaded
onto 200 mesh nickel formvar carbon coated grids (Electron
Microscopy Science, Hatfield, PA). MVs were then fixed in 3%
paraformaldheyde (PAF) in PBS containing 2% sucrose for 15 min
and permeabilized with cold methanol (220uC) for 10 min. After
extensive washing and blocking with 1% BSA in PBS pH 7.4,
MVs were immunolabeled with primary antibodies for 1 hour at
room temperature and after washings with PBS/BSA (pH 8.2),
MVs were incubated with 10 or 5 nm gold labeled goat anti-rabbit
of anti-mouse antibodies (BBInternational, Cardiff, UK) in PBS/
BSA pH 8.2 for 1 hour at room temperature. MVs were postfixed
in 2.5% gluteraldehyde, washed and after silver enhancement
(BBInternational), embedded in a mixture of uranyl acetate (0.8%)
and methyl cellulose (0.13%), and examined in a Jeol JEM 1010
electron microscope.
Table 5. Selectively expressed miRNAs from MSC MVs and
their cells of origin.
miRNAs
Expression in
MSC MVs Fold change
Expression
in MSCs Fold change
hsa-miR-223 6046219.0 hsa-miR-594 714.4656.3
hsa-miR-451 87.6677.2 hsa-miR-654 322.256227.8
hsa-miR-564 69.7620.9 hsa-miR-369-5p 152.3672.6
hsa-miR-502 11.362.0
hsa-miR-376a 1163.2
hsa-miR-362 6.360.7
hsa-miR-194 2.660.6
Expression of miRNAs in MSCs and their corresponding MVs was analyzed
separately (n = 4). Clustering similarities of MVs derived from MSCs and their
cells of origin detected miRNAs present only in MSCs or their MVs. Data are
expressed as fold change measured based on the normalized miRNA mean
differences (22DCt) 6 SD, between MSCs and their corresponding MVs.
doi:10.1371/journal.pone.0011803.t005
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Figure 5. MVs containing miRNAs. Fold change analyses of selected miRNAs in MVs from MSCs and HLSCs in respect to their cell of origin was
detected by qRT-PCR and expressed as Log of 22DCt (MVs versus cells). miRNA comparisons between cells and MVs were based on the relative
expression data normalized using the geometric mean value of four of the most stable miRNAs identified in the profiling between cells and MVs (see
Methods). The following miRNAs were tested: miR-221 (line1), miR-99a (line 2), miR-222 (line 3), miR-24 (line 4), miR-410 (line 5), miR-21 (line 6), miR-
100 (line 7), miR-214 (line 8), miR-31 (line9), miR-223 (line 12), miR-122 (line 13) and miR-451 (line 14). As control snoRNAs, RNU 44 (line 10) and RNU
48 (line 11) were used. In panel A, the dark dotted box indicate the miRNAs co-expressed by MVs and the cells of origin and the grey dotted box
indicate miRNAs enriched within MVs. Panel B and C are a magnification of the dark (B) and grey (C) boxes respectively. The boxed areas represent
the mean 6 quartile and the whiskers extend out to the minimum and maximum values. Anova with Newman-Keuls multicomparison test was
performed and all the reported miRNAs exhibited a significance ,0.001 in respect to the control snoRNAs.
doi:10.1371/journal.pone.0011803.g005
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Western Blot Analysis
MVs and cells were lysed at 4uC for 1 hour in a lysis buffer
(50 mM Tris-HCl, pH 8.3, containing 1% Triton X-100, 1 mM
PMSF, 10 mg/ml leupeptin, and 100 units/ml aprotinin). Aliquots
of the MV and cell lysates containing 30 mg of proteins, as
determined by Bradford method, were subjected to 4–15%
gradient SDS-PAGE under reducing conditions and electroblotted
onto nitrocellulose membrane filters as previously described [4].
The blots were blocked with 5% non fat milk in 20 mM Tris-HCl
pH 7.5, 500 mM NaCl plus 0.1% Tween (TBS-T). The MV
membranes were subsequently immunoblotted at 4uC with
relevant primary antibodies (anti-human TIA1, TIAR and HuR
from Santa Cruz Biotechnology; anti-human Ago2, Stau1, Stau2
and RPS29 from AbCam) or irrelevant isotypic controls at
appropriate concentration. The cell lysate membranes were
subsequently immunoblotted at 4uC with relevant primary
antibodies against cyclin D1 (AbCam), PTEN (Cell Signaling
Technology, Danvers, MA, USA), Bcl-2 (Santa Cruz Biotechnol-
ogy), AKT (Cell Signaling Technology) and b-actin (Santa Cruz
Biotechnology). After extensive washings with TBS-T, the blots
were incubated for one hour at room temperature with peroxydase
conjugated secondary antibodies (Santa Cruz Biotechnology),
washed with TBS-T, developed with ECL detection reagents
(Amersham) and detected by Chemidoc (Biorad).
In situ hybridization
In situ hybridization was conducted on HLSCs, MSCs and their
MVs and performed using a miRCURY LNA detection probe
against hsa-miR-24 (Exiqon, Vedbaek, Denmark), showing to be
highly expressed by cells and MVs. The probe used was
biotinylated at 59 of its sequence and a scramble-miR probe (59-
biotin) was used as control. Protocol was conducted according to
the manufacture instruction. Briefly, MVs were isolated and
spotted on formvar-carbon coated grid for electron microscopy
analysis. Cells were seeded into chamber slides (Nunc, Rochester,
NY, United States) and incubated under normal growth
conditions overnight, reaching 80% of confluence. Cells and
MVs were then fixed with 4% PAF for 30 min at room
temperature, washed three times with 1X PBS. For the in situ
hybridization on cells, HLSCs and MSCs were permeabilized at
4uC in 70% ethanol overnight. Hybridization with the LNA probe
(10 nM) was carried out at 20–22uC below the melting
temperature of the probe overnight after incubation in a pre-
hybridization buffer (50% Formamide, 5xSSC, 0.1%Tween,
9.2 mM citric acid for adjustment to pH 6, 50 mg/mL heparin,
500 mg/mL tRNAs) for 2 h at the temperature of annealing of the
probe (59uC) in a water bath. Prior to incubate the samples, the
LNA detection probe was warmed in the hybridization buffer at
80uC to linearize the probe. The day after the samples were rinsed
in stringent conditions (50% formamide, 26SSC at hybridization
temperature), washed for 1 h with a blocking solution (1% BSA in
PBS-T) at room temperature followed by an incubation with
10 nm gold-conjugated avidin (BBInternational) and a silver
enhancement (Silver enhancing kit, BBInternational). Grids were
then counterstained and examined with a Jeol JEM 1010 electron
microscope. For the immunofluorescence detection, cells and MVs
were incubated with a Atto-488 conjugated streptavidin (Sigma)
and analyzed by confocal microscopy.
Transient transfection assay
Transfections of siRNA and miRNAs to MSCs were performed
using the HiPerFect Transfection Reagent (Qiagen) according to
the manufacturer’s protocol. AllStars Negative Control siRNA
Alexa 488 (Qiagen, 100 nM) and FAM conjugated MISSIONH
microRNA Mimics (Sigma, hsa-miR-100 and hsa-miR-21,
100 nM) were used in each experiment.
Figure 6. Cellular processes overrepresented by validated and predictedmRNA targets of miRNAs co-expressed by MVs and cells. A
GO tree obtained from BiNGO, showing the hierarchy of gene ontology biological processes overrepresented by the validated and predicted targets
of miRNAs co-expressed by MVs and cells. (p,0.01, see the color bar). Node colors represent the statistical significance. The white nodes (p.0.01)
showed the relationships among their downstream nodes. The boxes indicated the overrepresented biological processes categorized into
development, catalytic activity, cell fate differentiation and metabolic processes.
doi:10.1371/journal.pone.0011803.g006
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Transfer of miRNAs to murine tubular epithelial cells
To analyze miRNAs transfer from MVs, mTEC were used.
mTEC were isolated, cultured and characterized as previously
described [8]. miRNA transfer experiments were conducted as
previously by Yuan [11]. Approximately 56105 cells/well of
mTECs were pre-plated in a 65 cm2 Petri dish, 1 day before the
stimulation. MSC MVs isolated from 8 T175 flasks were used for
each experiment and equally divided between all mTEC samples.
mTEC were co-incubated for different times with MSC MVs and
a transcription inhibitor, a-amanitin (Sigma, 50 mg/ml) or with a-
amanitin alone [27] to inhibit transcriptional activation induced
by MVs. Cells were washed with PBS twice, to eliminate any
residual of MSC MVs, then enzymatically dissociated from the
plates and washed with PBS. Cells were collected at time 0 and
after 12, 24 and 48 hours of stimulation with MVs plus a-amanitin
or with a-amanitin alone as control. Total RNA from mTEC was
isolated and qRT-PCR was performed for a subset of miRNAs
using the protocol described above. As an indirect measure of
miRNA transfer, we determined the difference in Ct values
between a-amanitin treated cells in the absence or in the presence
of MSC MVs at each experimental time point; a positive value
indicated transfer. If no signal was detected, a Ct value of 40 was
assigned to the sample. Moreover, to study the kinetic of MV
incorporation into mTEC, we incubated 10 mg of MVs, labeled
with PKH26 dye for 12 and 24 hours at 37uC. For miRNA
transfer studies, mTEC were also incubated for 3 hours at 37uC
with MVs isolated from siRNA-Alexa 488 or FAM-microRNA
Mimic transfected MSCs. MV uptake was evaluated for both the
experiments by confocal microscopy.
Clustering of miRNAs and similarity analyses
We adopted a two-phases approach consisting in a hierarchical
clustering followed by a similarity analysis. Raw data were
normalized considering the average Ct computed for each
clustering phase, and then subjected to hierarchical clustering
using a mean-centering data grouping miRNAs with a Ct value
mean difference lower than 1.2. Six miRNA groups were
identified between the miRNA expression patterns of each assay.
Groups generated from hierarchical clustering were then com-
pared between different sample through the similarity analyses
based on three miRNAs expression conditions, highly expressed
(normalized expression value lower than 0), expressed (normalized
expression value greater than 0) or not expressed. The process
identified several contingency tables where each miRNA was
classified in several categories that allowed identifying its behavior
[66]. Two similarity categories were defined: equally expressed,
where the included miRNAs were highly expressed, expressed or
not expressed; or differentially expressed, where the included
Figure 7. miRNA transfer and MV uptake by mTEC. Panel A: mTEC were incubated with MVs derived from MSCs for 12, 24 and 48 hours (h) at
37uC in the presence of 50 mg/ml a-amanitin to inhibit transcriptional activation in mTEC and the transfer of selected miRNAs was evaluated by qRT-
PCR. The difference in Ct values between a-amanitin treated mTEC alone or stimulated with MVs is shown for each miRNA. The snoRNA, RNU48 and
the miR-410, that was not present in MVs, were used as controls. Data are the mean 6 SD of four experiments. Panel B: Micrograph representative of
the incorporation of MVs labeled with PKH26 in mTEC evaluated by confocal microscopy after incubation for 12 and 24 hours at 37uC. Three
experiments were performed with similar results (original magnification X400). Panel C: To evaluate the transfer of miRNAs within mTEC we used two
reporter miRNAs, the Alexa-488 labeled siRNA or the FAM labeled microRNA Mimic (hsa-miR-21). mTEC were incubated for 3 hours at 37uC with MVs
isolated from MSCs transfected with Alexa-488 labeled siRNA (MV Alexa-488 siRNA) or with FAM labeled microRNA Mimic (MV FAM hsa-miR-21). The
uptake of MVs was evaluated by confocal microscopy. miRNAs incorporated within mTEC were detected as green fluorescence signal of Alexa-488 or
FAM fluorophores (Original magnification X400). Panel D: Downregulation in mTEC of proteins targeted by some of the enriched miRNAs present in
MVs, was evaluated by western blot analysis. mTEC were incubated at 37uC with 30 mg/ml of MVs derived from MSCs for 3, 12, 24 and 48 hours and
the cell lysates were submitted to Western Blot as described in Methods for detection of PTEN, cyclin D1, Bcl-2, AKT and as control Actin. mTEC
incubated for 48 hours in the absence of MVs were also used as control (Ctrl 48 h). Cell viability evaluated as trypan blue exclusion was 9860.7%.
Three experiments were conducted with similar results.
doi:10.1371/journal.pone.0011803.g007
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miRNAs had a complementary behavior between the considered
assays (less expressed to more expressed or vice versa). For both
the categories, we compared miRNA behavior between MSCs and
HLSCs, between all the cells and MVs or between cells and the
corresponding MVs, generating also sub-categories including only
MSCs, HLSCs or their corresponding MVs, to identify biological
relevant miRNAs.
Statistical analysis
Since in qRT-PCR, Ct scores greater than 35 are considered
non-specific [67], miRNAs that had a raw Ct value greater than
35, conserved in both preparations of MSCs, HLSCs or their
corresponding MVs, were not included in the final data analysis.
Using these filtering criteria, we removed from analysis, 187
miRNAs for MSCs, 195 for HLSCs, 199 for MSC MVs and 208
for HLSC MVs, respectively. The internal controls (snoRNAs) in
MVs were significantly different from that of their cells of origin.
Relative expression data were then normalized using the mean
expression value, calculated on the overall miRNA expression in
each array, according to a Ct detection cut-off of 35 PCR cycles as
described by Mestdagh et al [23]. The mean expression value
stability as normalizer was confirmed by geNorm analysis [23].
Fold change in miRNA expression was calculated based on the
normalized mean differences between cells, cells and MVs or
between cells and the corresponding MVs (22DCt).
Statistical analysis was performed by using the t test or ANOVA
with Newman-Keuls multicomparison test, where appropriate. A
p value of ,0.05 was considered significant.
Pathway analysis and prediction
Validated and predicted target genes for MV-miRNAs were
obtained from the online database, miRWalk (http://www.ma.
uni-heidelberg.de/apps/zmf/mirwalk). mirWalk miRNA target
prediction was provided by the match among four different
miRNA prediction programs (miRanda, miRDB, miRWalk and
TargetScan) (p-value ,0.01). Functional enrichment analysis and
network analysis were conducted using the BiNGO version 2.3
[25], a Cytoscape [26] plug-in to identify biological processes
overrepresented by target genes, resulted modulated by miRNAs
detected in MVs (miRNAs co-expressed by MSCs and HLSCs, by
cells and MVs or MV-enriched miRNAs). In the Gene Ontology
(GO) tree, enriched Gene Ontology biological processes are
represented by connected nodes with an associated statistical
significance (P values derived from a hypergeometric hypothesis
test in BiNGO). Biological functions showing p-value less than
0.05 were considered as significantly enriched.
Supporting Information
Table S1 Fold change analysis of miRNAs coexpressed by
MSCs and HLSCs. Normalized expression level of miRNAs from
MSCs and HLSCs that clustered in the same expression groups
are reported. The relative expression of miRNAs between MSCs
and HLSCs was defined as fold change evaluated as 2-deltaCt.
Found at: doi:10.1371/journal.pone.0011803.s001 (0.22 MB
DOC)
Table S2 GO biological functions of targets of overexpressed
miRNAs by cells and MVs. GO biological functions of predicted
and validated targets of miRNAs overexpressed by cells and MVs,
detected as % of cluster and total frequency of genes with a GO
annotation. Only clusters with p value ,0.05 are reported.
Found at: doi:10.1371/journal.pone.0011803.s002 (0.16 MB
DOC)
Table S3 GO biological functions of targets of miRNAs
selectively present in MVs derived from HLSCs. GO biological
functions of validated targets of miRNAs overexpressed by MVs
derived from HLSCs, detected as % of cluster and total frequency
of genes with a GO annotation. Only clusters with p value ,0.05
are reported.
Found at: doi:10.1371/journal.pone.0011803.s003 (0.20 MB
DOC)
Table S4 GO biological functions of targets of miRNAs
selectively present in MVs derived from MSCs. GO biological
functions of validated targets of miRNAs overexpressed by MVs
derived from MSCs, detected as % of cluster and total frequency
of genes with a GO annotation. Only clusters with p value ,0.05
are reported.
Found at: doi:10.1371/journal.pone.0011803.s004 (0.22 MB
DOC)
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